Related Experiment Videos
Neonatal risk scoring systems. Can they predict mortality and morbidity?
D K Richardson1, W O Tarnow-Mordi, G J Escobar
1Joint Program in Neonatology, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Boston, Massachusetts, USA. richardson@neonatology.bidmc.harvard.edu
Clinics in Perinatology
|October 21, 1998
Summary
Physiology-based illness severity scores effectively predict neonatal mortality and morbidity. Their primary value lies in improving quality and cost-effectiveness in neonatal intensive care units (NICUs).
Area of Science:
- Neonatal physiology
- Clinical informatics
- Healthcare quality improvement
Background:
- Physiology-based illness severity scores are increasingly utilized in clinical practice.
- While theoretical disadvantages exist, practical applications demonstrate significant advantages.
- Routine collection of these scores is becoming standard in many institutions.
Purpose of the Study:
- To evaluate the practical applications and predictive value of physiology-based illness severity scores in neonates.
- To assess the role of these scores in predicting mortality and morbidity.
- To determine the primary utility of these scoring systems in neonatal care.
Main Methods:
- Review of numerous studies comparing treatment groups, NICUs, countries, and eras.
- Analysis of practical applications and reported advantages versus theoretical disadvantages.
- Assessment of routine data collection of physiology-based newborn scores.
Main Results:
- Physiology-based scores demonstrate real-world advantages, outweighing theoretical disadvantages.
- Scores facilitate insightful comparisons across diverse clinical settings and time periods.
- Neonatal risk scoring systems successfully predict some mortality and morbidity.
Conclusions:
- Physiology-based illness severity scores are valuable tools in neonatal care.
- Their predictive function for mortality and morbidity is secondary to their role in quality and cost improvement.
- Future advancements are contingent on developing commercially viable applications.